Malaria, Cerebral: Clinical Trials

14 trials for Malaria, Cerebral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 unknown, 1 recruiting. 5 Phase 2, 5 Phase 3, 4 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Unknown 1
Phase 35Unknown 3, Completed 2
Phase 14Completed 3, Recruiting 1
Not applicable1Completed 1

Follow Malaria, Cerebral: new trials by email Literature Review of Malaria, Cerebral trials Research Report on Malaria, Cerebral

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DON in Pediatric Cerebral Malaria
6-diazo-5-oxo-L-norleucine (DON), Placebo - Malaria, Cerebral
Phase 1 / Phase 2RecruitingDouglas Postels, MD, MS1522022-08-162026-10-23
Automated Detection of Malarial Retinopathy in Patients Diagnosed With Cerebral Malaria
Automated software for malarial retinopathy detection - Cerebral Malaria, Malarial Retinopathy
CompletedVisionQuest Biomedical LLC8342022-03-152025-07-03
Treating Brain Swelling in Pediatric Cerebral Malaria
Mechanical ventilation, Hypertonic saline - Malaria, Cerebral
Phase 3CompletedMichigan State University572018-01-082025-03-17
A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM
Oral Levetiracetam, Standard AED - Seizure, Epilepsy
Phase 2CompletedUniversity of Rochester442014-01-012016-07-29
Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria
LEVETIRACETAM - Seizure, Epilepsy
Phase 1 / Phase 2CompletedUniversity of Rochester72013-01-012016-09-15
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Immunochromatographic HAT tests (DSD), Card Agglutination Trypanosoma Test, TB POC Nucleic Acid Amplification Test (Molbio Diagnostics) - Neurological Disorders, Cerebral Malaria
Phase 3CompletedInstitute of Tropical Medicine, Belgium3522012-09-012016-01-18
Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
inhaled nitric oxide, Placebo - Malaria, Cerebral
Phase 2CompletedEpicentre922011-09-012016-03-02
Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria
Cognitive rehabilitation training - Malaria, Cerebral
Not applicableCompletedMakerere University1232008-02-012012-12-06
Hyperphenylalaninemia in Cerebral Malaria
Plasmodium Falciparum Malaria
CompletedUniversity of Utah2852007-10-012012-10-22
Randomized Trial of Erythropoietin During Cerebral Malaria
Placebo, Erythropoietin - Cerebral Malaria
Phase 2 / Phase 3UnknownClaude Bernard University1202007-10-012008-06-13
Study of the Safety of Intravenous Artesunate
Intravenous Artesunate, Placebo - Malaria, Malaria, Cerebral
Phase 1CompletedU.S. Army Medical Research and Development Command262006-06-122018-10-25
Mannitol as Adjunct Therapy for Childhood Cerebral Malaria
Mannitol - Cerebral Malaria
Phase 3UnknownMakerere University1562004-10-012005-06-24
Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria
Intrarectal quinine - Cerebral Malaria
Phase 3UnknownMakerere University1082003-09-012005-08-04
Study of the Safety of Intravenous Artesunate
Intravenous artesunate - Malaria, Malaria, Cerebral
Phase 1CompletedU.S. Army Medical Research and Development Command402016-10-26

Narrower conditions

Malaria (7)  ·  Epilepsy (2)  ·  Malaria, Falciparum (2)  ·  Seizures (2)  ·  Coma (1)  ·  Meningitis, Bacterial (1)  ·  Meningitis, Cryptococcal (1)  ·  Neglected Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurosyphilis (1)  ·  Tuberculosis, Central Nervous System (1)

Broader conditions

Central Nervous System Diseases (14)  ·  Central Nervous System Infections (14)  ·  Central Nervous System Parasitic Infections (14)  ·  Central Nervous System Protozoal Infections (14)  ·  Infections (14)  ·  Mosquito-Borne Diseases (14)  ·  Parasitic Diseases (14)  ·  Protozoan Infections (14)  ·  Vector Borne Diseases (14)  ·  Nervous System Diseases (13)  ·  Malaria (7)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Neurologic Manifestations (3)  ·  Signs and Symptoms (3)  ·  Brain Diseases (2)

Interventions

Levetiracetam (2)  ·  Mannitol (2)  ·  Air (1)  ·  Cognitive Training (1)  ·  Diazooxonorleucine (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Erythropoietin (1)  ·  Nitric Oxide (1)  ·  Nitrogen (1)  ·  Respiration, Artificial (1)  ·  Saline Solution, Hypertonic (1)  ·  Sodium Chloride (1)  ·  epoetin beta (1)

Sponsors

Makerere University (3)  ·  U.S. Army Medical Research and Development Command (2)  ·  University of Rochester (2)  ·  Claude Bernard University (1)  ·  Douglas Postels, MD, MS (1)  ·  Epicentre (1)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Michigan State University (1)  ·  University of Utah (1)  ·  VisionQuest Biomedical LLC (1)

Countries

Malawi (5)  ·  Uganda (4)  ·  United States (2)  ·  Democratic Republic of the Congo (1)  ·  Mali (1)  ·  Tanzania (1)

Top investigators

Gretchen L Birbeck, M.D. (2)  ·  Peter J Weina, MD, PhD (2)  ·  Charles Ibingira, MMED (1)  ·  Donald L Granger, M.D. (1)  ·  Douglas Postels, MD (1)  ·  Emmanuel Bottieau, MD (1)  ·  Esther D. Mwaikambo, M.D. (1)  ·  Jane Achan, MBChB (1)  ·  Juliet Mwanga-Amumpaire, Dr (1)  ·  Marleen Boelaert, MD, PhD (1)  ·  Terrie E Taylor, DO (1)

Results publications

PMID 31672143, PMID 17958887, PMID 19630971, PMID 19852829, PMID 34020114, PMID 38279124, PMID 41748157

NIH funding

R01NS074409 (2), SB1AI162452 (1), U01AI126610 (1)